Aspirin with Low-Dose Ticagrelor or with Low-Dose Rivaroxaban for Secondary Prevention: A Cost per Outcome Analysis

ConclusionCombining aspirin with LD rivaroxaban provides better value for money than with LD ticagrelor for secondary prevention of MACE.
Source: American Journal of Cardiovascular Drugs - Category: Cardiology Source Type: research